Hypercapnic Respiratory Failure, Hypoxia, Intensive Care Unit, Nasal High Flow Therapy, Ventilatory Failure
Conditions
Brief summary
The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of participating centers in Iberoamerica. It will describe the indications for the use, the clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying in an intensive care unit in the participant centers in Iberoamerica.
Interventions
OTHERNo intervention
No intervention, observational study
Sponsors
Fundación Santa Fe de Bogota
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Over 18 years old * Admitted to medical or surgical ICU * Requirement of high nasal flow therapy
Exclusion criteria
* Post-extubation failure * Patient unable to protect airway * Diagnosed shock * Glasgow equal or under 8
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Hypoxemia | 15 days | PO2 under 60mmHg, or SatO2 under 80%; that leads to the instauration of invasive ventilation |
| Tachypnea | 15 days | Respiratory rate over 20; that leads to the instauration of invasive ventilation |
| Hypercapnia | 15 days | PCO2 over 55mmHg; that leads to the instauration of invasive ventilation |
Countries
Colombia, Dominican Republic, Mexico, Spain
Outcome results
None listed